James Eddings serves as Executive at THERAGENICS CORP, where they oversee executive responsibilities. Since joining the company, James Eddings has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 5, 2007 involved transacting 12,802 shares valued at $49.9K.
James Eddings currently holds 675,139 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Eddings has been a net neutral trader of TGX stock. They have purchased $0 and sold $0 worth of shares.
James Eddings's most recent insider trade was on Sep 5, 2007, when they sold 12,802 shares at $3.90 per share.
Get notified when new Form 4 filings are submitted
| $3.90 |
| Discretionary |
| Aug 2, 2006 | TGX | $257.1K | Award | 78,856 | $3.26 | Discretionary |
| Aug 2, 2006 | TGX | $2.0M | Award | 610,738 | $3.26 | Discretionary |